Kraig Biocraft Laboratories
Michigan-based Kraig Biocraft Laboratories develops high-strength, protein-based fibers for the textile industry using DNA technology.
- 30
- Public
Michigan-based Kraig Biocraft Laboratories develops high-strength, protein-based fibers for the textile industry using DNA technology.
kraiglabs.comCrawled Oct 15, 2026
The future is made in the laboratory
Kraig Biocraft Laboratories says it produces recombinant spider silk fibers and describes other designer protein-based polymer companies as potential competitors; it says those companies have dropped “spider silk” from product descriptions and marketing.
Kraig Biocraft Laboratories is the world leader in spider silk technologies, which offer superior strength, toughness, and flexibility.
Kraig Biocraft Laboratories is focused on genetically engineering next-generation polymers with unprecedented capabilities, such as recombinant spider silk.
Kraig Biocraft Laboratories says it does not currently collect users’ personal information, but may collect standard browser information primarily to analyze website traffic.
Kraig Biocraft Laboratories announces that it has shipped its first commercial order of spider silk yarn to a performance sports brand, marking a milestone for its recombinant spider silk platform. The shipment represents the first commercial revenue from the platform, as stated by the company.
Sep 2026MicroCapsNews article
Kraig Biocraft Laboratories completes a functional and living atlas gene library, calling it a major scientific milestone. The company says the library enables faster development of new spider silk production strains and advances its recombinant spider silk platform.
Sep 2026Kraig Biocraft Laboratories press releaseNews article
Kraig Biocraft Laboratories CEO Kim Thompson discusses the company’s spider silk technology and commercial production progress in a Pulse 2.0 interview. The interview covers Kraig Labs’ technological leadership, expanding market opportunities, and long-term vision for advanced materials as it pursues commercial-scale production of recombinant spider silk using its proprietary genetically engineered silkworm platform.
Jun 2026BioSpaceNews article
Kraig Biocraft Laboratories moves its 2026 production plan into execution, activating the first wave of materials for its spider silk scale-up initiative. The company moves bio-material into incubation ahead of its March production plan and says the release of initial production materials enables an expanded manufacturing pipeline and field-level implementation.
Feb 2026NasdaqNews article